Furthermore, DUSP1 downregulation was associated with activation of MAPK/p38 and MAPK/JNK signaling and accelerated development of hepatosteatosis in NAFLD patients 60. The gene discussed is MAPK8; the disease is metabolic dysfunction-associated steatotic liver disease.